Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer. (2021)
Attributed to:
3DBioNet: an integrated technological platform for 3D micro-tissues
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers13122940
PubMed Identifier: 34208295
Publication URI: http://europepmc.org/abstract/MED/34208295
Type: Journal Article/Review
Volume: 13
Parent Publication: Cancers
Issue: 12
ISSN: 2072-6694